Nuvation Bio and Eisai Enter into Exclusive Licensing Agreement for Taletrectinib in Europe and Additional Countries Outside U.S., China and Japan Nanotech Investing
Soleno Therapeutics Announces Select Preliminary Fourth Quarter and Full-Year 2025 Results Nanotech Investing
Rani Therapeutics Initiates Phase 1 Study of RT-114 RaniPill® for the Treatment of Obesity in Collaboration with ProGen Nanotech Investing
Cullinan Therapeutics Provides Corporate Update and Highlights Anticipated 2026 Milestones Nanotech Investing
Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases Nanotech Investing
Soleno Therapeutics Announces Publication of Results from Pivotal Study of VYKAT XR in the Journal of Clinical Endocrinology and Metabolism Nanotech Investing
Universal Ibogaine provides Bi-weekly Default Status Report on 2025 year-end filings and update on Restructuring process Nanotech Investing
